Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio de los Santos Gil

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|February 2, 2010
[Etravirine in special populations]Ignacio de los Santos Gil
Enfermedades Infecciosas Y Microbiologia Clinica|November 21, 2013
[Pharmacokinetic interactions]Piedad Arazo Garcés, Ignacio de los Santos Gil
Enfermedades Infecciosas Y Microbiologia Clinica|February 7, 2009
[Management of renal toxicity in HIV-positive patients. What to measure, how to measure it and how frequently]Guillermina Barril Cuadrado, Ignacio de Los Santos Gil
Enfermedades Infecciosas Y Microbiologia Clinica|October 22, 2013
[Neurosensory loss hearing of syphilitic etiology in a patient with human immunodeficiency virus infection]Jorge Antonio Valencia-La Rosa, Christian Gómez-Dávila, Jesús Sanz-Sanz, et al.
Gastroenterologia Y Hepatologia|September 25, 2021
Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antiviralsLucio J García-Fraile, Luisa García-Buey, Concepción Alonso Cerezo, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|November 7, 2017
[Prevalence of undiagnosed human immunodeficiency virus infection in an emergency department and the characteristics of newly diagnosed patients]Alberto Pizarro Portillo, Carmen Del Arco Galán, Ignacio de Los Santos Gil, et al.
Journal of the International Association of Providers of AIDS Care|August 20, 2020
Ambulatory Blood Pressure Monitoring in HIV-Infected Patients: Usefulness for Cardiovascular Risk AssessmentAna Gómez-Berrocal, Ignacio De Los Santos-Gil, Daniel Abad-Pérez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|January 12, 2015
[Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study]Pompeyo Viciana-Fernández, Vicenç Falcó, Manuel Castaño, et al.
The Journal of Infection|May 18, 2019
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeksAnaïs Corma-Gómez, Juan Macías, Dolores Merino Muñoz, et al.
Antiviral Therapy|December 4, 2014
Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfectionKarin Neukam, Daniela Munteanu, Sebastian Haubitz, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Enfermedades Infecciosas Y Microbiologia Clinica|February 2, 2010
[Etravirine in special populations]Ignacio de los Santos Gil
Enfermedades Infecciosas Y Microbiologia Clinica|November 21, 2013
[Pharmacokinetic interactions]Piedad Arazo Garcés, Ignacio de los Santos Gil
Enfermedades Infecciosas Y Microbiologia Clinica|February 7, 2009
[Management of renal toxicity in HIV-positive patients. What to measure, how to measure it and how frequently]Guillermina Barril Cuadrado, Ignacio de Los Santos Gil
Enfermedades Infecciosas Y Microbiologia Clinica|October 22, 2013
[Neurosensory loss hearing of syphilitic etiology in a patient with human immunodeficiency virus infection]Jorge Antonio Valencia-La Rosa, Christian Gómez-Dávila, Jesús Sanz-Sanz, et al.
Gastroenterologia Y Hepatologia|September 25, 2021
Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antiviralsLucio J García-Fraile, Luisa García-Buey, Concepción Alonso Cerezo, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|November 7, 2017
[Prevalence of undiagnosed human immunodeficiency virus infection in an emergency department and the characteristics of newly diagnosed patients]Alberto Pizarro Portillo, Carmen Del Arco Galán, Ignacio de Los Santos Gil, et al.
Journal of the International Association of Providers of AIDS Care|August 20, 2020
Ambulatory Blood Pressure Monitoring in HIV-Infected Patients: Usefulness for Cardiovascular Risk AssessmentAna Gómez-Berrocal, Ignacio De Los Santos-Gil, Daniel Abad-Pérez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|January 12, 2015
[Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study]Pompeyo Viciana-Fernández, Vicenç Falcó, Manuel Castaño, et al.
The Journal of Infection|May 18, 2019
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeksAnaïs Corma-Gómez, Juan Macías, Dolores Merino Muñoz, et al.
Antiviral Therapy|December 4, 2014
Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfectionKarin Neukam, Daniela Munteanu, Sebastian Haubitz, et al.
Pageof 3